By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cosmo Pharmaceuticals S.p.A. 

Via C. Colombo 1

Lainate    I – 20020  Italy
Phone: 39-02-9333-7614 Fax: 39-02-9333-7663



Company News
AIMM Therapeutics in Strategic Partnership With Cosmo Pharmaceuticals S.p.A. to Combine Cosmo's Extended Release Technology & AIMM's High Quality Antibodies to Successfully Combat Gastrointestinal Disease 12/19/2012 9:41:54 AM
Cosmo Pharmaceuticals S.p.A. CEO Sees $1.5 Billion Dye Luring Buyer by 2013 9/25/2012 7:55:14 AM
Cosmo Pharmaceuticals S.p.A. Announces Positive Top-Line Results in EU Phase III Clinical Study Evaluating Budesonide MMX In Ulcerative Colitis 11/8/2010 1:00:15 PM
Cosmo Pharmaceuticals S.p.A. Reports Exciting Results in P.O.C. Alopecia Study 10/6/2010 12:43:29 PM
Santarus Inc. (SNTS) and Cosmo Pharmaceuticals S.p.A.'s Anti-Inflammatory Drug Budesonide MMX Meets Late-Stage Goal 9/30/2010 6:54:19 AM
Cosmo Pharmaceuticals S.p.A. Reports Increased Revenues And Operating Profit In First-Half 2010 7/30/2010 12:52:48 PM
Cosmo Pharmaceuticals S.p.A. Reports Shire Pharmaceuticals (SHPGY) Receives LIALDA(R) Paragraph IV Notice Letter from Zydus Pharmaceuticals (USA) Inc. 6/1/2010 12:34:22 PM
Cosmo Pharmaceuticals S.p.A. Reports Good 2009 Results -- Strategic Goals Met - Confident Outlook For 2010 3/22/2010 2:27:52 PM
Cosmo Pharmaceuticals S.p.A. Announces Preliminary End Result Of Its Tender Offer For BioXell S.p.A. 3/1/2010 11:53:19 AM
Cosmo Pharmaceuticals S.p.A.'s CB-03-01 Phase II Pilot Study In Acne Demonstrates Superiority Over Retin A(R) 12/11/2009 10:16:30 AM